Suppr超能文献

氧化应激、纤溶酶原激活物抑制剂1与肺纤维化

Oxidative stress, plasminogen activator inhibitor 1, and lung fibrosis.

作者信息

Liu Rui-Ming

机构信息

Department of Environmental Health Sciences, School of Public Health, University of Alabama at Birmingham, Birmingham, Alabama 35294, USA.

出版信息

Antioxid Redox Signal. 2008 Feb;10(2):303-19. doi: 10.1089/ars.2007.1903.

Abstract

Fibrosis is characterized by excessive accumulation of extracellular matrix (ECM) in basement membranes and interstitial tissues, resulting from increased synthesis or decreased degradation of ECM or both. The plasminogen activator/plasmin system plays an important role in ECM degradation, whereas the plasminogen activator inhibitor 1 (PAI-1) is a physiologic inhibitor of plasminogen activators. PAI-1 expression is increased in the lung fibrotic diseases and in experimental fibrosis models. The deletion of the PAI-1 gene reduces, whereas the overexpression of PAI-1 enhances, the susceptibility of animals to lung fibrosis induced by different stimuli, indicating an important role of PAI-1 in the development of lung fibrosis. Many growth factors, including transforming growth factor beta (TGF-beta) and tumor necrosis factor alpha (TNF-alpha), as well as other chemicals/agents, induce PAI-1 expression in cultured cells and in vivo. Reactive oxygen and nitrogen species (ROS/RNS) have been shown to mediate the induction of PAI-1 by many of these stimuli. This review summarizes some recent findings that help us to understand the role of PAI-1 in the development of lung fibrosis and ROS/RNS in the regulation of PAI-1 expression during fibrogenesis.

摘要

纤维化的特征是细胞外基质(ECM)在基底膜和间质组织中过度积聚,这是由ECM合成增加或降解减少或两者兼而有之所致。纤溶酶原激活物/纤溶酶系统在ECM降解中起重要作用,而纤溶酶原激活物抑制剂1(PAI-1)是纤溶酶原激活物的生理抑制剂。PAI-1在肺纤维化疾病和实验性纤维化模型中的表达增加。PAI-1基因的缺失会降低动物对不同刺激诱导的肺纤维化的易感性,而PAI-1的过表达则会增强这种易感性,这表明PAI-1在肺纤维化的发展中起重要作用。许多生长因子,包括转化生长因子β(TGF-β)和肿瘤坏死因子α(TNF-α),以及其他化学物质/试剂,均可在培养细胞和体内诱导PAI-1表达。活性氧和氮物种(ROS/RNS)已被证明可介导许多这些刺激对PAI-1的诱导作用。本综述总结了一些最新发现,这些发现有助于我们理解PAI-1在肺纤维化发展中的作用以及ROS/RNS在纤维化形成过程中对PAI-1表达的调节作用。

相似文献

1
Oxidative stress, plasminogen activator inhibitor 1, and lung fibrosis.
Antioxid Redox Signal. 2008 Feb;10(2):303-19. doi: 10.1089/ars.2007.1903.
2
Plasminogen activator inhibitor-1 and diabetic nephropathy.
Nephrology (Carlton). 2005 Oct;10 Suppl:S11-3. doi: 10.1111/j.1440-1797.2005.00449.x.
5
Plasminogen activator inhibitor-1 suppresses profibrotic responses in fibroblasts from fibrotic lungs.
J Biol Chem. 2015 Apr 10;290(15):9428-41. doi: 10.1074/jbc.M114.601815. Epub 2015 Feb 3.
6
Plasminogen Activator Inhibitor Type-1 as a Regulator of Fibrosis.
J Cell Biochem. 2018 Jan;119(1):17-27. doi: 10.1002/jcb.26146. Epub 2017 Jun 12.
8
PAI-1 in tissue fibrosis.
J Cell Physiol. 2012 Feb;227(2):493-507. doi: 10.1002/jcp.22783.
9
Noninhibitory PAI-1 enhances plasmin-mediated matrix degradation both in vitro and in experimental nephritis.
Kidney Int. 2006 Aug;70(3):515-22. doi: 10.1038/sj.ki.5000353. Epub 2006 Jun 21.
10
Plasminogen activator inhibitor type 1 is a potential target in renal fibrogenesis.
Kidney Int. 2000 Nov;58(5):1841-50. doi: 10.1111/j.1523-1755.2000.00355.x.

引用本文的文献

1
"Eldorado" flower extract targets serpine 1 to attenuate inflammatory and antioxidant crosstalk in zebrafish.
Front Pharmacol. 2025 Jul 11;16:1612233. doi: 10.3389/fphar.2025.1612233. eCollection 2025.
2
SS-31: A promising therapeutic agent against bleomycin-induced pulmonary fibrosis in Mice.
PLoS One. 2025 Apr 29;20(4):e0315473. doi: 10.1371/journal.pone.0315473. eCollection 2025.
3
Nutraceutical COMP-4 confers protection against endothelial dysfunction through the eNOS/iNOS-NO-cGMP pathway.
PLoS One. 2025 Feb 6;20(2):e0316798. doi: 10.1371/journal.pone.0316798. eCollection 2025.
7
PAI-1 regulates AT2-mediated re-alveolarization and ion permeability.
Stem Cell Res Ther. 2023 Jul 27;14(1):185. doi: 10.1186/s13287-023-03414-4.
8
Oncostatin M, Serpins, and Oxidative Stress in Extracellular Matrix Remodeling and Arteriovenous Fistula Maturation.
Cardiol Cardiovasc Med. 2023;7(2):129-140. doi: 10.26502/fccm.92920318. Epub 2023 Apr 20.
10
Vascular Contribution to Lung Repair and Fibrosis.
Am J Respir Cell Mol Biol. 2023 Aug;69(2):135-146. doi: 10.1165/rcmb.2022-0431TR.

本文引用的文献

1
Glutathione suppresses TGF-beta-induced PAI-1 expression by inhibiting p38 and JNK MAPK and the binding of AP-1, SP-1, and Smad to the PAI-1 promoter.
Am J Physiol Lung Cell Mol Physiol. 2007 Nov;293(5):L1281-92. doi: 10.1152/ajplung.00128.2007. Epub 2007 Sep 21.
2
Protection from acute and chronic lung diseases by curcumin.
Adv Exp Med Biol. 2007;595:379-405. doi: 10.1007/978-0-387-46401-5_17.
4
Oxidative stress as a common pathway to chronic tubulointerstitial injury in kidney allografts.
Am J Physiol Renal Physiol. 2007 Aug;293(2):F445-55. doi: 10.1152/ajprenal.00037.2007. Epub 2007 Apr 25.
5
Regulation of TGF-beta1/MAPK-mediated PAI-1 gene expression by the actin cytoskeleton in human mesangial cells.
Exp Cell Res. 2007 Apr 1;313(6):1240-50. doi: 10.1016/j.yexcr.2007.01.011. Epub 2007 Jan 31.
6
Oxidative stress and lipid-derived inflammatory mediators during acute exacerbations of cystic fibrosis.
Respirology. 2007 Jan;12(1):63-9. doi: 10.1111/j.1440-1843.2006.00962.x.
7
Prevention of interstitial fibrosis of renal allograft by angiotensin II blockade.
Transplant Proc. 2006 Dec;38(10):3498-501. doi: 10.1016/j.transproceed.2006.10.085.
8
Antioxidants in cystic fibrosis. Conclusions from the CF antioxidant workshop, Bethesda, Maryland, November 11-12, 2003.
Free Radic Biol Med. 2007 Jan 1;42(1):15-31. doi: 10.1016/j.freeradbiomed.2006.09.022. Epub 2006 Sep 29.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验